Review
Published on 09 Aug 2022
Maintenance therapy for AML after allogeneic HCT
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.895771
- 11,590 views
- 9 citations
Type at least 3 characters
2,059 articles
articles
Brief Research Report
Published on 08 Aug 2022
Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.903691
- 4,934 views
- 2 citations
Original Research
Published on 05 Aug 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.901132
- 3,921 views
- 7 citations
Review
Published on 05 Aug 2022
Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.884723
- 6,917 views
- 8 citations
Brief Research Report
Published on 05 Aug 2022
Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.915629
- 2,791 views
- 3 citations
Case Report
Published on 05 Aug 2022
Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.934566
- 2,988 views
- 1 citation
Original Research
Published on 05 Aug 2022
Long-term treatment outcome of Castleman’s disease: A real-world experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.974770
- 7,136 views
- 6 citations
Original Research
Published on 05 Aug 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.894279
- 6,295 views
- 6 citations
Brief Research Report
Published on 05 Aug 2022
PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.957208
- 3,286 views
- 11 citations
Original Research
Published on 05 Aug 2022
Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.949534
- 5,555 views
- 11 citations
Systematic Review
Published on 05 Aug 2022
Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.951215
- 7,665 views
- 20 citations
Case Report
Published on 03 Aug 2022
Case Report: TEMPI syndrome: Report of three cases and treatment follow-up
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.949647
- 5,346 views
- 3 citations
Original Research
Published on 03 Aug 2022
Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.933619
- 4,796 views
- 4 citations
Brief Research Report
Published on 03 Aug 2022
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.911745
- 3,325 views
- 3 citations
Original Research
Published on 02 Aug 2022
Clinicopathologic study of mantle cell lymphoma with epstein-barr virus infection: A case series and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.933964
- 3,013 views
- 2 citations
Original Research
Published on 02 Aug 2022
iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.822805
- 7,214 views
- 38 citations
Mini Review
Published on 02 Aug 2022
Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.934008
- 7,980 views
- 24 citations
Case Report
Published on 28 Jul 2022
Case report and literature review: Hemophagocytic lymphohistiocytosis in a pregnant woman with systemic lupus erythematosus with Syntaxin 11 gene defect
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.937494
- 3,301 views
- 4 citations
Original Research
Published on 28 Jul 2022
Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.943151
- 6,209 views
- 27 citations
Original Research
Published on 26 Jul 2022
18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.894804
- 2,402 views
- 11 citations
Case Report
Published on 25 Jul 2022
Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.941633
- 13,152 views
- 10 citations
Editorial
Published on 19 Jul 2022
Editorial: Real World Outcomes of Lymphoma From India
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.922370
- 7,047 views
- 6 citations
Original Research
Published on 19 Jul 2022
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.932674
- 4,670 views
- 17 citations
Brief Research Report
Published on 19 Jul 2022
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.919278
- 3,325 views
- 6 citations